Literature DB >> 20958846

An examination of drug craving over time in abstinent methamphetamine users.

Gantt P Galloway1, Edward G Singleton, Raymond Buscemi, Matthew J Baggott, René M Dickerhoof, John E Mendelson.   

Abstract

Craving for addictive drugs may predict relapse in abstinent addicts. To assess relationships between craving and use, we examined changes in craving for methamphetamine (MA) in a sample of 865 outpatients in a multisite 16-week MA-treatment study. Craving was assessed on a 0-100 scale, and MA use was assessed by self-report and confirmed by urinalysis. We hypothesized that the magnitude of craving would decline (decay) with increased time of abstinence, and that decay would be greater for more frequent MA users, and greater for intravenous (IV) users and smokers as compared to those who used MA intranasally. Craving declined significantly as the number of weeks of consecutive abstinence increased. Rate of decay was greater for IV users and smokers as compared to both intranasal users and oral users, but not for more frequent users of MA. Rate of decay was independent of age, gender, and race/ethnicity. The trajectory to 0 (no) craving was 1 week shorter for females than males because females had significantly lower pretreatment craving scores compared to males. This study confirms that the sooner MA-dependent people are able to quit using and the longer that they are able to stay abstinent, the more likely it is that their craving for MA will decrease over time. © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20958846     DOI: 10.1111/j.1521-0391.2010.00082.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  15 in total

1.  Using ecological momentary assessment to assess the temporal relationship between sleep quality and cravings in individuals recovering from substance use disorders.

Authors:  Lindsey K Freeman; Nisha C Gottfredson
Journal:  Addict Behav       Date:  2017-11-12       Impact factor: 3.913

2.  Acute modafinil exposure reduces daytime sleepiness in abstinent methamphetamine-dependent volunteers.

Authors:  James J Mahoney; Brian J Jackson; Ari D Kalechstein; Richard De La Garza; Lee C Chang; Thomas F Newton
Journal:  Int J Neuropsychopharmacol       Date:  2012-01-04       Impact factor: 5.176

3.  Neonatal exposure to lipopolysaccharide enhances methamphetamine-induced reinstated behavioral sensitization in adult rats.

Authors:  Lu-Tai Tien; Zhengwei Cai; Philip G Rhodes; Lir-Wan Fan
Journal:  Behav Brain Res       Date:  2011-06-06       Impact factor: 3.332

4.  A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction.

Authors:  G P Galloway; R Buscemi; J R Coyle; K Flower; J D Siegrist; L A Fiske; M J Baggott; L Li; D Polcin; C Y A Chen; J Mendelson
Journal:  Clin Pharmacol Ther       Date:  2010-12-22       Impact factor: 6.875

5.  Sensitivity to rewarding or aversive effects of methamphetamine determines methamphetamine intake.

Authors:  S Shabani; C S McKinnon; C Reed; C L Cunningham; T J Phillips
Journal:  Genes Brain Behav       Date:  2011-05-31       Impact factor: 3.449

Review 6.  Monoclonal antibodies as pharmacokinetic antagonists for the treatment of (+)-methamphetamine addiction.

Authors:  S Michael Owens; William T Atchley; Michael D Hambuchen; Eric C Peterson; W Brooks Gentry
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

Review 7.  The clinical significance of drug craving.

Authors:  Stephen T Tiffany; Jennifer M Wray
Journal:  Ann N Y Acad Sci       Date:  2011-12-16       Impact factor: 5.691

8.  Sex Differences in the Association Between Internalizing Symptoms and Craving in Methamphetamine Users.

Authors:  Emily E Hartwell; Nathasha R Moallem; Kelly E Courtney; Suzette Glasner-Edwards; Lara A Ray
Journal:  J Addict Med       Date:  2016 Nov/Dec       Impact factor: 3.702

9.  Boundary conditions of methamphetamine craving.

Authors:  Richard B Lopez; Chukwudi Onyemekwu; Carl L Hart; Kevin N Ochsner; Hedy Kober
Journal:  Exp Clin Psychopharmacol       Date:  2015-08-24       Impact factor: 3.157

10.  Developmental timing of first drug treatment and 10-year patterns of drug use.

Authors:  Elizabeth Evans; Libo Li; Christine Grella; Mary-Lynn Brecht; Yih-Ing Hser
Journal:  J Subst Abuse Treat       Date:  2012-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.